The United States Federal Drug Administration (FDA) has approved a new gene therapy treatment for a rare blood clotting disease called Hemophilia B. The drug Hemgenix costs US$ 3.5mn (Rs 28.52 Crore). Until now, the world’s costliest drug was Zolgensma – a drug for gene therapy used to treat children below two years diagnosed withRead more